HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to bacillus Calmette-Guérin

Journal of Urology

Volumn 189, Issue 4, 2013, Pages 1541-1546

  Zhang, Guangjian ^a   Chen, Fanghong ^a   Cao, Yanli ^a   Johnson, Bryon ^a   See, William A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

BCG vaccine; carcinoma; HMGB1 protein; urinary bladder; urothelium

Indexed keywords

BCG VACCINE; HIGH MOBILITY GROUP B1 PROTEIN; SHORT HAIRPIN RNA;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; HMGB1 PROTEIN; MICE;

EID: 84875940317     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.123     Document Type: Article

References (28)

1. M. Babjuk, W. Oosterlinck, R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997
2. W. Kassouf, A.M. Kamat, A. Zlotta Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy Can J Urol 4 2010 168
3. M.C. Hall, S.S. Chang, G. Dalbagni Guideline for the Management of Non-muscle Invasive Bladder Cancer: (Stages Ta, T1, and Tis): AUA Update 2007 2007 American Urological Association Education and Research Linthicum
4. G. Zhang, F. Chen, W.A. See Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway Urol Oncol 25 2007 221
5. F.H. Chen, S.A. Crist, G.J. Zhang Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway J Urol 168 2002 786
6. F. Chen, G. Zhang, W.A. See MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin J Urol 182 2009 2932
7. F. Chen, G. Zhang, W.A. See BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking BMC Urol 5 2005 8
8. F. Chen, G. Zhang, W.A. See Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury J Urol 178 2007 2166
9. A. Raucci, R. Palumbo, M.E. Bianchi HMGB1: a signal of necrosis Autoimmunity 40 2007 285
10. W.A. See, G. Zhang, F. Chen Bacille-Calmette Guerin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1 BJU Int 103 2009 1714
11. T. Mossman Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55
12. C. Ninalga, A. Loskog, M. Klevenfeldt CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer J Immunol 28 2005 20
13. J.E. Ellerman, C.K. Brown, M. de Vera Masquerader: high mobility group box-1 and cancer Clin Cancer Res 13 2007 2836
14. U. Andersson, H. Wang, K. Palmblad High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 2000 565
15. C.J. Treutiger, G.E. Mullins High mobility group 1 B-box mediates activation of human endothelium J Immunol Methods 254 2003 375
16. H.J. Zeh 3rd, M.T. Lotze Addicted to death: invasive cancer and the immune response to unscheduled cell death J Immunol 28 2005 1
17. H. Kuniyasu, Y. Chihara, H. Kondo Amphotericin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer Oncol Rep 10 2003 1863
18. H.J. Huttunen, C. Fages, J. Kuja-Panula Receptor for advanced glycation end products-binding COOH-terminal motif of amphotericin inhibits invasive migration and metastasis J Can Res 62 2002 4805
19. Q. He, C.H. Liang, S.J. Lippard Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin Proc Natl Acad Sci U S A 97 2000 5768
20. D. Tang, R. Kang, M.T. Lotze High-mobility group box 1 and cancer Biochim Biophys Acta 1799 2010 131
21. L. Ulloa, D. Messmer High-mobility group box 1 (HMGB1) protein: friend and foe Cytokine Growth Factor Rev 17 2006 189
22. U. Andersson, H. Erlandsson-Harris, H. Yang HMGB1 as a DNA-binding cytokine J Leukoc Biol 72 2002 1084
23. A.K. Mossberg, Y. Hou, M. Svensson HAMLET treatment delays bladder cancer development J Urol 183 2010 1590
24. N.A. Bockholt, M.J. Knudson, J.R. Henning Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer J Urol 187 2012 2228
25. Leite KR, Chade DC and Sanudo A: Effects of curcumin in an orthotopic murine bladder tumor model. Int Braz J Urol 35: 599.
26. T.L. Ratliff Role of the immune response in BCG for bladder cancer Eur Urol 21 suppl 1992 17
27. S. Brandau, J. Riemensberger, A. Böhle Role of IFN gamma and IL-10 in immunotherapy of bladder cancer with Mycobacterium bovis BCG Immunobiology 203 2000 350
28. A. Böhle, S. Brandau Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer J Urol 170 2003 964